A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Similarly, experts suggest that type two diabetes drug Ozempic, could actually be increasing penis sizes via illusion.

Ozempic (semaglutide) and Wegovy (semaglutide) are brand-name injections. ... You can use each pen for 4 or 8 doses, depending on the strength and dose your doctor has prescribed.

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...

Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in ...

More than one in four UK adults are obese, but only a small number will be eligible for the latest treatment from the NHS ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug ...